Literature DB >> 31820258

Deconvolution Analysis by Non-linear Regression Using a Convolution-Based Model: Comparison of Nonparametric and Parametric Approaches.

Roberto Gomeni1, Françoise Bressolle-Gomeni2.   

Abstract

The convolution-based modeling approach has been shown to be flexible and easy to implement for performing a deconvolution analysis and for assessing in vitro/in vivo correlation using non-linear regression and a pre-specified model describing the in vivo drug absorption. A generalization of this method has been developed using a nonparametric description of the in vivo drug absorption process in replacement of a model-based definition. A comparison of the parametric and nonparametric deconvolution and convolution analyses was conducted on the pharmacokinetic (PK) data observed in four published studies after the administration of an extended-release formulation of methylphenidate at the dose of 18 mg. All the analyses were conducted using a conventional non-linear regression software (NONMEM). The results of the deconvolution analysis indicated that the parametric and nonparametric approaches performed similarly. The parametric approach described the input function using a double Weibull equation (6 parameters) while the nonparametric approach described the input function using a piecewise approximation (12-13 parameters). The validation of the results of the deconvolution analysis was conducted by comparing observed and predicted PK concentrations by the convolution analysis. The performance of the parametric and nonparametric approaches for assessing deconvolution was evaluated using the Akaike and the Bayesian information criteria. These criteria indicated that, despite the similar results obtained with the two approaches, the nonparametric approach provided better results. In conclusion, these results indicated that the nonparametric approach should be considered as the preferred approach for conducting a deconvolution analysis.

Entities:  

Keywords:  convolution; convolution-based model; deconvolution; nonparametric approach

Mesh:

Substances:

Year:  2019        PMID: 31820258     DOI: 10.1208/s12248-019-0389-8

Source DB:  PubMed          Journal:  AAPS J        ISSN: 1550-7416            Impact factor:   4.009


  20 in total

1.  A semiparametric deconvolution model to establish in vivo-in vitro correlation applied to OROS oxybutynin.

Authors:  M Pitsiu; G Sathyan; S Gupta; D Verotta
Journal:  J Pharm Sci       Date:  2001-06       Impact factor: 3.534

2.  Per cent absorbed time plots derived from blood level and/or urinary excretion data.

Authors:  J G WAGNER; E NELSON
Journal:  J Pharm Sci       Date:  1963-06       Impact factor: 3.534

3.  Population pharmacodynamic modeling of various extended-release formulations of methylphenidate in children with attention deficit hyperactivity disorder via meta-analysis.

Authors:  Holly Kimko; Ekaterina Gibiansky; Leonid Gibiansky; H Lynn Starr; Joris Berwaerts; Joseph Massarella; Frank Wiegand
Journal:  J Pharmacokinet Pharmacodyn       Date:  2012-01-22       Impact factor: 2.745

4.  A comparison of six deconvolution techniques.

Authors:  F N Madden; K R Godfrey; M J Chappell; R Hovorka; R A Bates
Journal:  J Pharmacokinet Biopharm       Date:  1996-06

Review 5.  Concepts, properties, and applications of linear systems to describe distribution, identify input, and control endogenous substances and drugs in biological systems.

Authors:  D Verotta
Journal:  Crit Rev Biomed Eng       Date:  1996

6.  New method for calculating the intrinsic absorption rate of drugs.

Authors:  J C Loo; S Riegelman
Journal:  J Pharm Sci       Date:  1968-06       Impact factor: 3.534

7.  Linear and nonlinear system approaches in pharmacokinetics: how much do they have to offer? I. General considerations.

Authors:  P Veng-Pedersen
Journal:  J Pharmacokinet Biopharm       Date:  1988-08

8.  Steady-state bioavailability of extended-release methylphenidate (MPH-MLR) capsule vs. immediate-release methylphenidate tablets in healthy adult volunteers.

Authors:  Akwete Adjei; Robert J Kupper; Nathan S Teuscher; Sharon Wigal; Floyd Sallee; Ann Childress; Scott H Kollins; Laurence Greenhill
Journal:  Clin Drug Investig       Date:  2014-11       Impact factor: 2.859

9.  Utility of PBPK Absorption Modeling to Guide Modified Release Formulation Development of Gaboxadol, a Highly Soluble Compound With Region-Dependent Absorption.

Authors:  Filippos Kesisoglou; Anand Balakrishnan; Kimberly Manser
Journal:  J Pharm Sci       Date:  2016-01-11       Impact factor: 3.534

10.  Basic concepts in population modeling, simulation, and model-based drug development-part 2: introduction to pharmacokinetic modeling methods.

Authors:  D R Mould; R N Upton
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2013-04-17
View more
  4 in total

1.  Comparison of Alternative Population Modeling Approaches for Implementing a Level A IVIVC and for Assessing the Time-Scaling Factor Using Deconvolution and Convolution-Based Methods.

Authors:  Roberto Gomeni; Françoise Bressolle-Gomeni
Journal:  AAPS J       Date:  2020-04-15       Impact factor: 4.009

2.  Screening of Bioequivalent Extended-Release Formulations for Metformin by Principal Component Analysis and Convolution-Based IVIVC Approach.

Authors:  Yufeng Zhang; Hua Liu; Minghui Johnson Tang; Nicolas James Ho; Tsun Lam Shek; Zhijun Yang; Zhong Zuo
Journal:  AAPS J       Date:  2021-03-04       Impact factor: 4.009

3.  Modeling Complex Pharmacokinetics of Long-Acting Injectable Products Using Convolution-Based Models With Nonparametric Input Functions.

Authors:  Roberto Gomeni; Françoise Bressolle-Gomeni
Journal:  J Clin Pharmacol       Date:  2021-03-15       Impact factor: 3.126

4.  Inferring pulmonary exposure based on clinical PK data: accuracy and precision of model-based deconvolution methods.

Authors:  Anneke Himstedt; Jens Markus Borghardt; Sebastian Georg Wicha
Journal:  J Pharmacokinet Pharmacodyn       Date:  2021-09-28       Impact factor: 2.745

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.